Sudden Cardiac Death Clinical Trial 2017-078WIRB

[LCID Study Number: 2017-078WIRB]

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)

The purpose of this study is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for ICD therapy.

Disease/Condition: Sudden Cardiac Death

Department: Cardiology – Anticoagulation

Status: Active, Not Recruiting

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-1901

Protocol #: 2017-078WIRB
Principal Investigator(s): Ghulam M. Chaudhry
Study Coordinator(s): Jean Byrne
Trial Phase: Sponsor Initiated Study Observational